Global Radiopharmaceuticals in Nuclear Medicine Market Status, Trends and COVID-19
In the past few years, the Radiopharmaceuticals in Nuclear Medicine market experienced a
huge change under the influence of COVID-19, the global market size of
Radiopharmaceuticals in Nuclear Medicine reached 4953.3 million $ in 2021 from xx in
2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus
Cases have exceeded 500 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Radiopharmaceuticals in
Nuclear Medicine market and global economic environment, we forecast that the global
market size of Radiopharmaceuticals in Nuclear Medicine will reach 6310.0 million $ in
2027 with a CAGR of % from 2022-2027.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Radiopharmaceuticals in Nuclear Medicine Market
Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive
analysis of the global Radiopharmaceuticals in Nuclear Medicine market , This Report
covers the manufacturer data, including: sales volume, price, revenue, gross margin,
business distribution etc., these data help the consumer know about the competitors better.
This report also covers all the regions and countries of the world, which shows the regional
development status, including market size, volume and value, as well as price data. Besides,
the report also covers segment data, including: type wise, industry wise, channel wise etc.
all the data period is from 2016-2021, this report also provide forecast data from 2022-
2027.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Application Segmentation
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2022-2027)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
huge change under the influence of COVID-19, the global market size of
Radiopharmaceuticals in Nuclear Medicine reached 4953.3 million $ in 2021 from xx in
2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus
Cases have exceeded 500 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Radiopharmaceuticals in
Nuclear Medicine market and global economic environment, we forecast that the global
market size of Radiopharmaceuticals in Nuclear Medicine will reach 6310.0 million $ in
2027 with a CAGR of % from 2022-2027.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Radiopharmaceuticals in Nuclear Medicine Market
Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive
analysis of the global Radiopharmaceuticals in Nuclear Medicine market , This Report
covers the manufacturer data, including: sales volume, price, revenue, gross margin,
business distribution etc., these data help the consumer know about the competitors better.
This report also covers all the regions and countries of the world, which shows the regional
development status, including market size, volume and value, as well as price data. Besides,
the report also covers segment data, including: type wise, industry wise, channel wise etc.
all the data period is from 2016-2021, this report also provide forecast data from 2022-
2027.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Application Segmentation
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2022-2027)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
SECTION 1 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET OVERVIEW
1.1 Radiopharmaceuticals in Nuclear Medicine Market Scope
1.2 COVID-19 Impact on Radiopharmaceuticals in Nuclear Medicine Market
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Status and Forecast Overview
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Status 2016-2021
1.3.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2022-2027
SECTION 2 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Radiopharmaceuticals in Nuclear Medicine Sales Volume
2.2 Global Manufacturer Radiopharmaceuticals in Nuclear Medicine Business Revenue
SECTION 3 MANUFACTURER RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE BUSINESS INTRODUCTION
3.1 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Introduction
3.1.1 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business
Distribution by Region
3.1.3 Bracco Imaging S.P.A. Interview Record
3.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Profile
3.1.5 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
3.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Introduction
3.2.1 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Distribution by Region
3.2.3 Interview Record
3.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Overview
3.2.5 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Product Specification
3.3 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Introduction
3.3.1 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Distribution
by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Overview
3.3.5 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Product Specification
SECTION 4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Region)
4.1 North America Country
4.1.1 United States Radiopharmaceuticals in Nuclear Medicine Market Size and Price
Analysis 2016-2021
4.1.2 Canada Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.1.3 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.2.2 Argentina Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.3 India Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.4 Korea Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Price
Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.4.2 UK Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.4.3 France Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.4.4 Spain Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.4.5 Italy Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.5 Middle East and Africa
4.5.1 Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.5.2 Middle East Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.6 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Region)
Analysis 2016-2021
4.7 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Region)
Analysis
SECTION 5 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Product Type)
5.1 Product Introduction by Type
5.1.1 Diagnostic Radiopharmaceuticals Product Introduction
5.1.2 Therapy Radiopharmaceuticals Product Introduction
5.1.3 Enriched Stable Isotopes Product Introduction
5.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Therapy
Radiopharmaceuticals016-2021
5.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Therapy
Radiopharmaceuticals016-2021
5.4 Different Radiopharmaceuticals in Nuclear Medicine Product Type Price 2016-2021
5.5 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Type)
Analysis
SECTION 6 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Application)
6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Application 2016-
2021
6.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application 2016-
2021
6.2 Radiopharmaceuticals in Nuclear Medicine Price in Different Application Field 2016-
1.1 Radiopharmaceuticals in Nuclear Medicine Market Scope
1.2 COVID-19 Impact on Radiopharmaceuticals in Nuclear Medicine Market
1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Status and Forecast Overview
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Status 2016-2021
1.3.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast 2022-2027
SECTION 2 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Radiopharmaceuticals in Nuclear Medicine Sales Volume
2.2 Global Manufacturer Radiopharmaceuticals in Nuclear Medicine Business Revenue
SECTION 3 MANUFACTURER RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE BUSINESS INTRODUCTION
3.1 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Introduction
3.1.1 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business
Distribution by Region
3.1.3 Bracco Imaging S.P.A. Interview Record
3.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Profile
3.1.5 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
3.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Introduction
3.2.1 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales
Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Distribution by Region
3.2.3 Interview Record
3.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Business Overview
3.2.5 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine
Product Specification
3.3 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Introduction
3.3.1 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Distribution
by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Business Overview
3.3.5 Manufacturer three Radiopharmaceuticals in Nuclear Medicine Product Specification
SECTION 4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Region)
4.1 North America Country
4.1.1 United States Radiopharmaceuticals in Nuclear Medicine Market Size and Price
Analysis 2016-2021
4.1.2 Canada Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.1.3 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.2.2 Argentina Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.3 India Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.3.4 Korea Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Price
Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.4.2 UK Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.4.3 France Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.4.4 Spain Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.4.5 Italy Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-
2021
4.5 Middle East and Africa
4.5.1 Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.5.2 Middle East Radiopharmaceuticals in Nuclear Medicine Market Size and Price Analysis 2016-2021
4.6 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Region)
Analysis 2016-2021
4.7 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Region)
Analysis
SECTION 5 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Product Type)
5.1 Product Introduction by Type
5.1.1 Diagnostic Radiopharmaceuticals Product Introduction
5.1.2 Therapy Radiopharmaceuticals Product Introduction
5.1.3 Enriched Stable Isotopes Product Introduction
5.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Therapy
Radiopharmaceuticals016-2021
5.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Therapy
Radiopharmaceuticals016-2021
5.4 Different Radiopharmaceuticals in Nuclear Medicine Product Type Price 2016-2021
5.5 Global Radiopharmaceuticals in Nuclear Medicine Market Segmentation (By Type)
Analysis
SECTION 6 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION (BY
Application)
6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Application 2016-
2021
6.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application 2016-
2021
6.2 Radiopharmaceuticals in Nuclear Medicine Price in Different Application Field 2016-
